Chau Q. Khuong

Chau joined OrbiMed Advisors in 2003 and is a Private Equity Partner focused on structured investments in private and public biopharmaceutical and medical device companies. Mr. Khuong has been extensively involved with development and commercial stage companies in multiple therapeutic areas from cancer to anti-infectives to liver diseases and ophthalmology. He is currently a Board Director or Observer at Aerpio (NASDAQ: ARPO), Graybug Vision, Inspire Medical Systems (NYSE: INSP), Kandy, Nerre, and Synlogic (NASDAQ: SYBX).